Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 588

1.

Combined treatment of hypertrophic and keloid scars with intralesional injection of corticosteroids and laser-assisted corticosteroid delivery.

Benzaquen M, Collet-Villette AM, Delaporte E.

Dermatol Ther. 2019 Oct 19:e13126. doi: 10.1111/dth.13126. [Epub ahead of print] No abstract available.

PMID:
31628774
2.

Rituximab is an Effective Treatment in Patients with Pemphigus Vulgaris and Demonstrates a Steroid-Sparing Effect.

Chen DM, Odueyungbo A, Csinady E, Gearhart L, Lehane P, Cheu M, Maho-Vaillant M, Prost-Squarcioni C, Hebert V, Houivet E, Calbo S, Caillot F, Golinski ML, Labeille B, Picard-Dahan C, Paul C, Richard MA, Bouaziz JD, Duvert-Lehembre S, Bernard P, Caux F, Alexandre M, Ingen-Housz-Oro S, Vabres P, Delaporte E, Quereux G, Dupuy A, Debarbieux S, Avenel-Audran M, D'Incan M, Bedane C, Bénéton N, Jullien D, Dupin N, Misery L, Machet L, Beylot-Barry M, Dereure O, Sassolas B, Benichou J, Musette P, Joly P; French Study Group on Autoimmune Bullous Diseases.

Br J Dermatol. 2019 Sep 5. doi: 10.1111/bjd.18482. [Epub ahead of print]

PMID:
31487383
3.

[Nodulocystic eruption induced by sorafenib].

Chambelland A, Koeppel MC, Desmedt E, Fongue J, Buono JP, Berbis P, Delaporte E.

Ann Dermatol Venereol. 2019 Oct;146(10):646-654. doi: 10.1016/j.annder.2019.06.002. Epub 2019 Jul 28. French.

PMID:
31362839
4.

Dolutegravir-Based or Low-Dose Efavirenz-Based Regimen for the Treatment of HIV-1.

NAMSAL ANRS 12313 Study Group, Kouanfack C, Mpoudi-Etame M, Omgba Bassega P, Eymard-Duvernay S, Leroy S, Boyer S, Peeters M, Calmy A, Delaporte E.

N Engl J Med. 2019 Aug 29;381(9):816-826. doi: 10.1056/NEJMoa1904340. Epub 2019 Jul 24.

PMID:
31339676
5.

Multiple venous malformations revealing a familial cerebral cavernomatosis.

Benzaquen M, Fareau J, Riccardi F, Philip-Sarles N, Bertrand F, Berbis P, Delaporte E.

Clin Exp Dermatol. 2019 Jul 19. doi: 10.1111/ced.14051. [Epub ahead of print] No abstract available.

PMID:
31323127
6.

Cost-Effectiveness of Three Alternative Boosted Protease Inhibitor-Based Second-Line Regimens in HIV-Infected Patients in West and Central Africa.

Boyer S, Nishimwe ML, Sagaon-Teyssier L, March L, Koulla-Shiro S, Bousmah MQ, Toby R, Mpoudi-Etame MP, Ngom Gueye NF, Sawadogo A, Kouanfack C, Ciaffi L, Spire B, Delaporte E; 2-Lady Group.

Pharmacoecon Open. 2019 Jul 4. doi: 10.1007/s41669-019-0157-9. [Epub ahead of print]

7.

Septic shock secondary to an acute necrotizing community-acquired pneumonia with bacteremia due to Pseudomonas aeruginosa.

Riviere P, Patin D, Delaporte E, Mahfoudi H, Lecailtel S, Poher F, Villette P, Duclaux J, Jouault P, Brunin G.

IDCases. 2019 May 16;17:e00563. doi: 10.1016/j.idcr.2019.e00563. eCollection 2019.

8.

Chronic kidney disease and HIV in the era of antiretroviral treatment: findings from a 10-year cohort study in a west African setting.

Kaboré NF, Poda A, Zoungrana J, Da O, Ciaffi L, Semdé A, Yaméogo I, Sawadogo AB, Delaporte E, Meda N, Limou S, Cournil A.

BMC Nephrol. 2019 May 7;20(1):155. doi: 10.1186/s12882-019-1335-9.

9.

Comparative immuno-virological and clinical responses to antiretroviral therapy between HIV-1 group O- and HIV-1 group M-infected patients (ANRS 12168 DynaMO study).

Kouanfack C, Unal G, Schaeffer L, Kfutwah A, Aghokeng A, Mougnutou R, Tchemgui-Noumsi N, Alessandri-Gradt E, Delaporte E, Simon F, Vray M, Plantier JC.

Clin Infect Dis. 2019 May 7. pii: ciz371. doi: 10.1093/cid/ciz371. [Epub ahead of print]

PMID:
31063537
10.

2018 Ebola virus disease outbreak in Équateur Province, Democratic Republic of the Congo: a retrospective genomic characterisation.

Mbala-Kingebeni P, Pratt CB, Wiley MR, Diagne MM, Makiala-Mandanda S, Aziza A, Di Paola N, Chitty JA, Diop M, Ayouba A, Vidal N, Faye O, Faye O, Karhemere S, Aruna A, Nsio J, Mulangu F, Mukadi D, Mukadi P, Kombe J, Mulumba A, Duraffour S, Likofata J, Pukuta E, Caviness K, Bartlett ML, Gonzalez J, Minogue T, Sozhamannan S, Gross SM, Schroth GP, Kuhn JH, Donaldson EF, Delaporte E, Sanchez-Lockhart M, Peeters M, Muyembe-Tamfum JJ, Alpha Sall A, Palacios G, Ahuka-Mundeke S.

Lancet Infect Dis. 2019 Jun;19(6):641-647. doi: 10.1016/S1473-3099(19)30124-0. Epub 2019 Apr 15.

PMID:
31000465
11.

Medical countermeasures during the 2018 Ebola virus disease outbreak in the North Kivu and Ituri Provinces of the Democratic Republic of the Congo: a rapid genomic assessment.

Mbala-Kingebeni P, Aziza A, Di Paola N, Wiley MR, Makiala-Mandanda S, Caviness K, Pratt CB, Ladner JT, Kugelman JR, Prieto K, Chitty JA, Larson PA, Beitzel B, Ayouba A, Vidal N, Karhemere S, Diop M, Diagne MM, Faye M, Faye O, Aruna A, Nsio J, Mulangu F, Mukadi D, Mukadi P, Kombe J, Mulumba A, Villabona-Arenas CJ, Pukuta E, Gonzalez J, Bartlett ML, Sozhamannan S, Gross SM, Schroth GP, Tim R, Zhao JJ, Kuhn JH, Diallo B, Yao M, Fall IS, Ndjoloko B, Mossoko M, Lacroix A, Delaporte E, Sanchez-Lockhart M, Sall AA, Muyembe-Tamfum JJ, Peeters M, Palacios G, Ahuka-Mundeke S.

Lancet Infect Dis. 2019 Jun;19(6):648-657. doi: 10.1016/S1473-3099(19)30118-5. Epub 2019 Apr 15.

PMID:
31000464
12.

[Update of the French recommendations for the management of pemphigus].

Jelti L, Prost-Squarcioni C, Ingen-Housz-Oro S, Caux F, Bernard P, Bedane C, Alexandre M, Dereure O, Quereux G, Le Bidre E, Plée J, Picard-Dahan C, Le Roux-Villet C, Duvert-Lehembre S, Richard MA, Delaporte E, Debarbieux S, Jullien D, D'Incan M, Konstantinou MP, Bouaziz JD, Tancrède-Bohin E, Doutre MS, Bourgault Villada I, Cordel N, Sassolas B, Viguier MA, Mellottée B, Jouen F, Hebert V, Joly P; Centre de référence des maladies bulleuses auto-immunes (MALIBUL); Groupe Bulles de la SFD et la Filière des maladies rares dermatologiques (FIMARAD).

Ann Dermatol Venereol. 2019 Apr;146(4):279-286. doi: 10.1016/j.annder.2019.01.018. Epub 2019 Mar 29. French. No abstract available.

PMID:
30929874
13.

A single typical trichoscopic feature is predictive of tinea capitis: a prospective multicentre study.

Dhaille F, Dillies AS, Dessirier F, Reygagne P, Diouf M, Baltazard T, Lombart F, Hébert V, Chopinaud M, Verneuil L, Becquart C, Delaporte E, Lok C, Chaby G.

Br J Dermatol. 2019 Nov;181(5):1046-1051. doi: 10.1111/bjd.17866. Epub 2019 Apr 29.

PMID:
30844082
14.

Desensitization protocol for angio-oedema induced by encorafenib in a patient with metastatic melanoma.

Brue A, Benzaquen M, Bonnet N, Koeppel MC, Default A, Delaporte E, Berbis P.

J Eur Acad Dermatol Venereol. 2019 Jul;33(7):e271-e272. doi: 10.1111/jdv.15544. Epub 2019 Mar 27. No abstract available.

PMID:
30835914
15.

Prevalence of infection among asymptomatic and paucisymptomatic contact persons exposed to Ebola virus in Guinea: a retrospective, cross-sectional observational study.

Diallo MSK, Rabilloud M, Ayouba A, Touré A, Thaurignac G, Keita AK, Butel C, Kpamou C, Barry TA, Sall MD, Camara I, Leroy S, Msellati P, Ecochard R, Peeters M, Sow MS, Delaporte E, Etard JF; Contactebogui Study Group.

Lancet Infect Dis. 2019 Mar;19(3):308-316. doi: 10.1016/S1473-3099(18)30649-2. Epub 2019 Feb 11.

PMID:
30765243
16.

Extensive Serological Survey of Multiple African Nonhuman Primate Species Reveals Low Prevalence of Immunoglobulin G Antibodies to 4 Ebola Virus Species.

Ayouba A, Ahuka-Mundeke S, Butel C, Mbala Kingebeni P, Loul S, Tagg N, Villabona-Arenas CJ, Lacroix A, Ndimbo-Kumugo SP, Keita AK, Toure A, Couacy-Hymann E, Calvignac-Spencer S, Leendertz FH, Formenty P, Delaporte E, Muyembe-Tamfum JJ, Mpoudi Ngole E, Peeters M.

J Infect Dis. 2019 Oct 8;220(10):1599-1608. doi: 10.1093/infdis/jiz006.

PMID:
30657940
17.

A community outbreak of Legionnaires' disease in Geneva, Switzerland, June to September 2017.

Zanella MC, Yerly S, Cherkaoui A, Renzi G, Mamin A, Lourenço Cordes L, Delaporte E, Baranczuk-Turska Z, Keiser O, Schrenzel J, Harbarth S, Gaia V, Kaiser L.

Swiss Med Wkly. 2018 Dec 2;148:w14687. doi: 10.4414/smw.2018.14687. eCollection 2018 Nov 19.

18.

Journées dermatologiques de Paris 2018.

Delaporte E; au nom du Comité de Sélection.

Ann Dermatol Venereol. 2018 Dec;145(12S):S1-S4. doi: 10.1016/j.annder.2018.10.022. Epub 2018 Nov 16. French. No abstract available.

PMID:
30449591
19.

[Recurrent pyogenic granuloma].

Roberge M, Levavasseur M, Darras S, Capelle C, Becquart C, Vonarx M, Martin de Lassalle E, Delaporte E, Staumont-Salle D.

Ann Dermatol Venereol. 2018 Dec;145(12):806-808. doi: 10.1016/j.annder.2018.09.596. Epub 2018 Nov 8. French. No abstract available.

PMID:
30415932
20.

Heterogeneity of virological suppression in the national antiretroviral programme of Cameroon (ANRS 12288 EVOLCAM).

Liégeois F, Eymard-Duvernay S, Boyer S, Maradan G, Kouanfack C, Domyeum J, Boyer V, Mpoudi-Ngolé E, Spire B, Delaporte E, Vidal L, Kuaban C, Laurent C; EVOLCAM study group.

HIV Med. 2019 Jan;20(1):38-46. doi: 10.1111/hiv.12681. Epub 2018 Oct 25.

PMID:
30362279
21.

Survey of Ebola Viruses in Frugivorous and Insectivorous Bats in Guinea, Cameroon, and the Democratic Republic of the Congo, 2015-2017.

De Nys HM, Kingebeni PM, Keita AK, Butel C, Thaurignac G, Villabona-Arenas CJ, Lemarcis T, Geraerts M, Vidal N, Esteban A, Bourgarel M, Roger F, Leendertz F, Diallo R, Ndimbo-Kumugo SP, Nsio-Mbeta J, Tagg N, Koivogui L, Toure A, Delaporte E, Ahuka-Mundeke S, Tamfum JM, Mpoudi-Ngole E, Ayouba A, Peeters M.

Emerg Infect Dis. 2018 Dec;24(12):2228-2240. doi: 10.3201/eid2412.180740. Epub 2018 Dec 17.

22.

Large International Validation of ABSIS and PDAI Pemphigus Severity Scores.

Hébert V, Boulard C, Houivet E, Duvert Lehembre S, Borradori L, Della Torre R, Feliciani C, Fania L, Zambruno G, Camaioni DB, Didona B, Marinovic B, Schmidt E, Schumacher N, Hünefeld C, Schanz S, Kern JS, Hofmann S, Bouyeure AC, Picard-Dahan C, Prost-Squarcioni C, Caux F, Alexandre M, Ingen-Housz-Oro S, Bagot M, Tancrede-Bohin E, Bouaziz JD, Franck N, Vabres P, Labeille B, Richard MA, Delaporte E, Dupuy A, D'Incan M, Quereux G, Skowro F, Paul C, Livideanu CB, Beylot-Barry M, Doutre MS, Avenel-Audran M, Bedane C, Bernard P, Machet L, Maillard H, Jullien D, Debarbieux S, Sassolas B, Misery L, Abasq C, Dereure O, Lagoutte P, Ferranti V, Werth VP, Murrell DF, Hertl M, Benichou J, Joly P; French Study Group on Autoimmune Bullous Skin Diseases; Autoimmune Bullous Skin Disease Task Force of the European Academy of Dermatology and Venereology.

J Invest Dermatol. 2019 Jan;139(1):31-37. doi: 10.1016/j.jid.2018.04.042. Epub 2018 Oct 6. Review.

PMID:
30301637
23.

Incidence and Mortality of Pemphigus in France.

Jelti L, Cordel N, Gillibert A, Lacour JP, Uthurriague C, Doutre MS, Delaporte E, Duvert-Lehembre S, Quereux G, Dupuy A, Adamski H, Bedane C, Misery L, Abasq Thomas C, Fleuret C, Bernard P, Chaby G, D'incan M, Verneuil L, Litrowski N, Joly P; French Study Group on Autoimmune Blistering Diseases.

J Invest Dermatol. 2019 Feb;139(2):469-473. doi: 10.1016/j.jid.2018.07.042. Epub 2018 Sep 17. No abstract available.

PMID:
30236611
24.

ART initiation in an outpatient treatment center in Dakar, Senegal: A retrospective cohort analysis (1998-2015).

Ngom NF, Faye MA, Ndiaye K, Thiam A, Ndour CT, Etard JF, Sow PS, Seydi M, Delaporte E, Cournil A.

PLoS One. 2018 Sep 19;13(9):e0202984. doi: 10.1371/journal.pone.0202984. eCollection 2018.

25.

Rapid Confirmation of the Zaire Ebola Virus in the Outbreak of the Equateur Province in the Democratic Republic of Congo: Implications for Public Health Interventions.

Mbala-Kingebeni P, Villabona-Arenas CJ, Vidal N, Likofata J, Nsio-Mbeta J, Makiala-Mandanda S, Mukadi D, Mukadi P, Kumakamba C, Djokolo B, Ayouba A, Delaporte E, Peeters M, Muyembe Tamfum JJ, Ahuka-Mundeke S.

Clin Infect Dis. 2019 Jan 7;68(2):330-333. doi: 10.1093/cid/ciy527.

26.

Serological Evidence of Ebola Virus Infection in Rural Guinea before the 2014 West African Epidemic Outbreak.

Keita AK, Butel C, Thaurignac G, Diallo A, Nioke T, Traoré F, Koivogui L, Peeters M, Delaporte E, Ayouba A.

Am J Trop Med Hyg. 2018 Aug;99(2):425-427. doi: 10.4269/ajtmh.18-0105. Epub 2018 May 31.

27.

[Imported malaria in Geneva between 2005 and 2016].

Cordaillat R, Delaporte E, Chappuis F.

Rev Med Suisse. 2018 May 2;14(605):941-943. French.

PMID:
29722501
28.

Cryptococcal Antigen Screening in Asymptomatic HIV-Infected Antiretroviral Naïve Patients in Cameroon and Evaluation of the New Semi-Quantitative Biosynex CryptoPS Test.

Temfack E, Kouanfack C, Mossiang L, Loyse A, Fonkoua MC, Molloy SF, Koulla-Shiro S, Delaporte E, Dromer F, Harrison T, Lortholary O.

Front Microbiol. 2018 Mar 13;9:409. doi: 10.3389/fmicb.2018.00409. eCollection 2018.

29.

The fourth HIV epidemic.

Laborde-Balen G, Taverne B, Ndour CT, Kouanfack C, Peeters M, Ndoye I, Delaporte E.

Lancet Infect Dis. 2018 Apr;18(4):379-380. doi: 10.1016/S1473-3099(18)30167-1. Epub 2018 Mar 21. No abstract available.

PMID:
29582762
30.

Short Communication: Nucleoside Reverse Transcriptase Inhibitors with Reduced Predicted Activity Do Not Impair Second-Line Therapy with Lopinavir/Ritonavir or Darunavir/Ritonavir.

Villabona-Arenas CJ, Eymard-Duvernay S, Aghokeng A, Guichet E, Toure-Kane C, Bado G, Koulla-Shiro S, Delaporte E, Ciaffi L, Peeters M.

AIDS Res Hum Retroviruses. 2018 Jun;34(6):477-480. doi: 10.1089/AID.2017.0290. Epub 2018 Apr 23.

PMID:
29575909
31.

Implementation and evaluation of a therapeutic patient education programme during a clinical trial in Yaoundé, Cameroon - Trial ANRS-12286/MOBIDIP.

Galy A, Ciaffi L, Mberyo GM, Mbouyap P, Abessolo H, Toby R, Essomba F, Lamarre G, Bikié A, Bell O, Koulla-Shiro S, Delaporte E.

Patient Educ Couns. 2018 Jul;101(7):1262-1269. doi: 10.1016/j.pec.2018.01.021. Epub 2018 Feb 1.

PMID:
29433950
32.

First field evaluation of the optimized CE marked Abbott protocol for HIV RNA testing on dried blood spot in a routine clinical setting in Vietnam.

Taieb F, Tran Hong T, Ho HT, Nguyen Thanh B, Pham Phuong T, Viet Ta D, Le Thi Hong N, Ba Pham H, Nguyen LTH, Nguyen HT, Nguyen TT, Tuaillon E, Delaporte E, Le Thi H, Tran Thi Bich H, Nguyen TA, Madec Y.

PLoS One. 2018 Feb 9;13(2):e0191920. doi: 10.1371/journal.pone.0191920. eCollection 2018.

33.

SMARCAD1 Haploinsufficiency Underlies Huriez Syndrome and Associated Skin Cancer Susceptibility.

Günther C, Lee-Kirsch MA, Eckhard J, Matanovic A, Kerscher T, Rüschendorf F, Klein B, Berndt N, Zimmermann N, Flachmeier C, Thuß T, Lucas N, Marenholz I, Esparza-Gordillo J, Hübner N, Traupe H, Delaporte E, Lee YA.

J Invest Dermatol. 2018 Jun;138(6):1428-1431. doi: 10.1016/j.jid.2018.01.015. Epub 2018 Feb 1. No abstract available.

34.

Divergent HIV-1 strains (CRF92_C2U and CRF93_cpx) co-circulating in the Democratic Republic of the Congo: Phylogenetic insights on the early evolutionary history of subtype C.

Villabona Arenas CJ, Vidal N, Ahuka Mundeke S, Muwonga J, Serrano L, Muyembe JJ, Boillot F, Delaporte E, Peeters M.

Virus Evol. 2017 Nov 10;3(2):vex032. doi: 10.1093/ve/vex032. eCollection 2017 Jul.

35.

Comparative typing analyses of clinical and environmental strains of the Cryptococcus neoformans/Cryptococcus gattii species complex from Ivory Coast.

Kassi FK, Bellet V, Drakulovski P, Krasteva D, Roger F, Valérie BA, Aboubakar T, Doumbia A, Kouakou GA, Delaporte E, Reynes J, Yavo W, Menan HIE, Bertout S.

J Med Microbiol. 2018 Jan;67(1):87-96. doi: 10.1099/jmm.0.000654. Epub 2017 Dec 7.

PMID:
29214970
36.

TDF and quantitative ultrasound bone quality in African patients on second line ART, ANRS 12169 2LADY sub-study.

Kabore FN, Eymard-Duvernay S, Zoungrana J, Badiou S, Bado G, Héma A, Diouf A, Delaporte E, Koulla-Shiro S, Ciaffi L, Cournil A.

PLoS One. 2017 Nov 8;12(11):e0186686. doi: 10.1371/journal.pone.0186686. eCollection 2017.

37.

Journées dermatologiques de Paris 2017.

Delaporte E; Comité de Sélection.

Ann Dermatol Venereol. 2017 Dec;144(12S):S1-S4. doi: 10.1016/j.annder.2017.10.003. Epub 2017 Oct 26. French. No abstract available.

PMID:
29107343
38.

Comparison of different nucleic acid preparation methods to improve specific HIV-1 RNA isolation for viral load testing on dried blood spots.

Guichet E, Serrano L, Laurent C, Eymard-Duvernay S, Kuaban C, Vidal L, Delaporte E, Ngole EM, Ayouba A, Peeters M.

J Virol Methods. 2018 Jan;251:75-79. doi: 10.1016/j.jviromet.2017.10.014. Epub 2017 Oct 14.

PMID:
29038002
39.

Efficacy of combining pulse corticotherapy and methotrexate in alopecia areata: Real-life evaluation.

Alkeraye S, Becquart C, Delaporte E, Staumont-Sallé D.

J Dermatol. 2017 Dec;44(12):e319-e320. doi: 10.1111/1346-8138.14013. Epub 2017 Sep 22. No abstract available.

PMID:
28940756
40.

Reply.

Hereth Hébert E, Resnikoff S, March L, Delaporte E.

Am J Ophthalmol. 2017 Sep;181:180. doi: 10.1016/j.ajo.2017.06.032. Epub 2017 Jul 31. No abstract available.

PMID:
28774555
41.

Die oralen Auswirkungen von Morbus Crohn: Beschreibung von neun Fällen.

Sahin T, Brygo A, Delaporte E, Ferri J.

Swiss Dent J. 2017;127(7-8):644-653. German, French.

42.

Factors associated with the choice of the first biologic in psoriasis: real-life analysis from the Psobioteq cohort.

Sbidian E, Giboin C, Bachelez H, Paul C, Beylot-Barry M, Dupuy A, Viguier M, Lacour JP, Schmutz JL, Bravard P, Mahé E, Beneton N, Misery L, Delaporte E, Modiano P, Barbarot S, Regnier E, Jullien D, Richard MA, Joly P, Tubach F, Chosidow O.

J Eur Acad Dermatol Venereol. 2017 Dec;31(12):2046-2054. doi: 10.1111/jdv.14406. Epub 2017 Jul 16.

43.

Boosted protease inhibitor monotherapy versus boosted protease inhibitor plus lamivudine dual therapy as second-line maintenance treatment for HIV-1-infected patients in sub-Saharan Africa (ANRS12 286/MOBIDIP): a multicentre, randomised, parallel, open-label, superiority trial.

Ciaffi L, Koulla-Shiro S, Sawadogo AB, Ndour CT, Eymard-Duvernay S, Mbouyap PR, Ayangma L, Zoungrana J, Gueye NFN, Diallo M, Izard S, Bado G, Kane CT, Aghokeng AF, Peeters M, Girard PM, Le Moing V, Reynes J, Delaporte E; MOBIDIP study group.

Lancet HIV. 2017 Sep;4(9):e384-e392. doi: 10.1016/S2352-3018(17)30069-3. Epub 2017 May 28.

PMID:
28566227
44.

Efficacy and Tolerance of Anti-Tumor Necrosis Factor α Agents in Cutaneous Sarcoidosis: A French Study of 46 Cases.

Heidelberger V, Ingen-Housz-Oro S, Marquet A, Mahevas M, Bessis D, Bouillet L, Caux F, Chapelon-Abric C, Debarbieux S, Delaporte E, Duval-Modeste AB, Fain O, Joly P, Marchand-Adam S, Monfort JB, Noël N, Passeron T, Ruivard M, Sarrot-Reynauld F, Verrot D, Bouvry D, Fardet L, Chosidow O, Sève P, Valeyre D.

JAMA Dermatol. 2017 Jul 1;153(7):681-685. doi: 10.1001/jamadermatol.2017.1162. Erratum in: JAMA Dermatol. 2017 Aug 1;153(8):837.

45.
46.

Extensive levamisole-induced vasculitis.

Desvignes C, Becquart C, Launay D, Terriou L, Patenotre P, Deheul S, Peytavin G, Dupin N, Delaporte E, Staumont-Sallé D.

Clin Exp Dermatol. 2017 Jun;42(4):413-415. doi: 10.1111/ced.13085. Epub 2017 Apr 10.

PMID:
28397288
47.

Full Genome Characterization of a New Simian Immune Deficiency Virus Lineage in a Naturally Infected Cercopithecus ascanius whitesidei in the Democratic Republic of Congo Reveals High Genetic Diversity Among Red-Tailed Monkeys in Central and Eastern Africa.

Ahuka-Mundeke S, Mbala-Kingebeni P, Ndimbo-Kumogo SP, Foncelle C, Lunguya-Metila O, Muyembe-Tamfum JJ, Delaporte E, Peeters M, Ayouba A.

AIDS Res Hum Retroviruses. 2017 Jul;33(7):735-739. doi: 10.1089/aid.2017.0027. Epub 2017 Apr 6.

48.

Depressive symptoms among survivors of Ebola virus disease in Conakry (Guinea): preliminary results of the PostEboGui cohort.

Keita MM, Taverne B, Sy Savané S, March L, Doukoure M, Sow MS, Touré A, Etard JF, Barry M, Delaporte E; PostEboGui Study Group.

BMC Psychiatry. 2017 Apr 4;17(1):127. doi: 10.1186/s12888-017-1280-8.

49.

Characteristics of the musculoskeletal symptoms observed among survivors of Ebola virus disease in the Postebogui cohort in Guinea.

Pers YM, Sow MS, Taverne B, March L, Izard S, Étard JF, Barry M, Touré A, Delaporte E.

Rheumatology (Oxford). 2017 Dec 1;56(12):2068-2072. doi: 10.1093/rheumatology/kex074.

PMID:
28371810
50.

First case of mixed infection with Cryptococcus deuterogattii and Cryptococcus neoformans VNI in an Ivorian HIV-positive patient.

Kassi FK, Bellet V, Doumbia A, Krasteva D, Drakulovski P, Kouakou GA, Gatchitch F, Delaporte E, Reynes J, Mallié M, Menan HI, Bertout S.

JMM Case Rep. 2016 Aug 30;3(4):e005037. doi: 10.1099/jmmcr.0.005037. eCollection 2016 Aug.

Supplemental Content

Loading ...
Support Center